Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-06-07 @ 5:44 PM
Study NCT ID:
NCT00906594
Status:
COMPLETED
Last Update Posted:
2015-08-18
First Post:
2009-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure
Sponsor:
University of Sao Paulo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Merck-USP-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None